Acrivon Therapeutics ($ACRV) Insider Trading & Smart Money Activity

Acrivon Therapeutics, Inc. · Latest filing Oct 5, 2026

Acrivon Therapeutics, Inc. ($ACRV) has 1 insider trade on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($585.06), net -$585.06.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

1

Net insider $ (12 mo)

-$585.06

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

ACRV insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	1 · $585.06	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ACRV insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 5, 2026	Insider	Miller MaryChief Legal Officer	Sell (Open-market sale)	294 sh	$585.06						—

1W / 1M / 6M = how ACRV moved from the trade or filing date.

Insider trading in ACRV: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Miller Mary	Chief Legal Officer	1	-$585.06		Oct 5, 2026

Frequently asked questions

Are ACRV insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $585.06, a net -$585.06.

What is the latest insider trade in ACRV?

Miller Mary, Chief Legal Officer filed a sell (open-market sale) of 294 sh worth $585.06 on Oct 5, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.